Geriatrics RehabilitationNCT07041996
Sarcopenia Screening Application for Sarcopenia
An observational study of Geriatrics Rehabilitation, run by Universitas Padjadjaran at 1 site in Indonesia.
Trial summary
Patients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Geriatrics Rehabilitation
- What is being tested?
- Mobile-based SARC-F screening application
- How many people
- 10 participants
- Where
- 1 siteIndonesia
- Study dates
- 20 Jun 2025to 20 Sep 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The accessible population is patients over 60 years of age who visit Geriatric Polyclinic in Bandung
Who may be able to join
- Patients who agree to participate in this study
- Patients over 60 years old with or without caregivers
- Patients with or without caregivers with a mobile phone
- Agree to participate in the black-box testing and sign the informed consent form
- Complete the whole sequence of the trial
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Mobile Phone-Based Sarcopenia Screening Application for Early Detection of Sarcopenia
Patients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia.
Read the detailed description
Patients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia. The aim of this study was to develop a mobile application for self-screening of sarcopenia in the elderly specifically in Indonesia using the SARC-F questionnaire. This application is expected to improve accessibility, cost-effectiveness, and ease of health education, enabling early detection and rapid intervention to reduce the disease burden of sarcopenia.
- Conditions
- Geriatrics Rehabilitation
- Being tested
- Mobile-based SARC-F screening application
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mobile-based SARC-F screening applicationDiagnostic test
SARC-F mobile application as a digital health intervention for sarcopenia risk assessment.
| Study group | Role | What they receive |
|---|---|---|
| Older adults (≥60 years) visiting the Geriatric Clinic | Patients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia Receives: Diagnostic Test: Mobile-based SARC-F screening application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sarcopenia status in mobile phone applications
Using Sarcopenia Questionnaire (SARC-F), score in numerical 0-10
Measured: 6 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jun 2025
- Study start20 Jun 2025
- Primary completion20 Sep 2025
- Study completion20 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Geriatrics RehabilitationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universitas Padjadjaran
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Irma Ruslina Defi, Universitas Padjadjaran
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07041996
- Sponsor's protocol ID
- IKFR.12.06.25
- Status last verified
- Apr 2026
- First submitted
- 13 Jun 2025
- Last updated
- 6 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mobile Phone-Based Sarcopenia Screening Application for Early Detection of Sarcopenia
- ClinicalTrials.gov ID
- NCT07041996
- Acronym / sponsor ID
- IKFR.12.06.25
- Conditions
- Geriatrics Rehabilitation
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- Universitas PadjadjaranUniversity, hospital or other
- Study start
- 20 Jun 2025 (actual)
- Primary completion
- 20 Sep 2025 (actual)
- Study completion
- 20 Sep 2025 (actual)
- First posted
- 27 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia.
Detailed description
Patients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia. The aim of this study was to develop a mobile application for self-screening of sarcopenia in the elderly specifically in Indonesia using the SARC-F questionnaire. This application is expected to improve accessibility, cost-effectiveness, and ease of health education, enabling early detection and rapid intervention to reduce the disease burden of sarcopenia.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Older adults (≥60 years) visiting the Geriatric Clinic | – | Diagnostic Test: Mobile-based SARC-F screening applicationPatients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The accessible population is patients over 60 years of age who visit Geriatric Polyclinic in Bandung
Key inclusion criteria (5 listed)
- Patients who agree to participate in this study
- Patients over 60 years old with or without caregivers
- Patients with or without caregivers with a mobile phone
- Agree to participate in the black-box testing and sign the informed consent form
- Complete the whole sequence of the trial
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mobile-based SARC-F screening applicationSARC-F mobile application as a digital health intervention for sarcopenia risk assessment. | Diagnostic test | Older adults (≥60 years) visiting the Geriatric Clinic |
Primary outcome
Sarcopenia status in mobile phone applications
Time frame: 6 month
Using Sarcopenia Questionnaire (SARC-F), score in numerical 0-10
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2026.
Related trials for Geriatrics Rehabilitation
Active, not recruiting
Comparative Effects of Balance and Inspiratory Muscle Training in Older Adults
Geriatric, Geriatrics Rehabilitation
Not yet recruitingObservational study
Understanding Dance for Falls Prevention
Older Adults (65 Years and Older), Geriatric
Not yet recruiting
The ACT-ON: A Geriatric 5-Ms-Guided Physical Therapy Intervention for Knee Osteo-Arthritis in Older Adults.
Rehabilitation, Excercise
Not yet recruiting
Digitally Assisted Rehabilitation at Home for Older Adults After Hip Surgery (GRIMSEL)
Hip Surgery, Rehabilitation Program
Enrolling by invitation
Clinical Efficacy of Exoskeleton Robot-Assisted Rehabilitation on Lower Limb Functional Recovery in Elderly Patients With Hip Fracture
Hip Fracture, Geriatrics
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Geriatrics Rehabilitation, run by Universitas Padjadjaran at 1 site in Indonesia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sarcopenia status in mobile phone applications (time frame: 6 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026; AzTrials last refreshed its copy on 27 Oct 2026.